Kesko Oyj
KKOYFOTCConsumer Defensive● Active
$23.98
+$0.00(+0.00%)
Market Cap$9.6B
P/E Ratio—
52W High$23.98
52W Low$17.64
Kesko Oyj（KKOYF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · KKOYF · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $12.47B | $11.92B | $11.78B | $11.81B | $11.30B |
| Cost of Revenue | $10.67B | $10.21B | $10.11B | $10.07B | $9.65B |
| Gross Profit | $0.30B | $1.71B | $1.68B | $1.74B | $1.65B |
| Gross Margin %(computed) | 2.39% | 14.38% | 14.23% | 14.75% | 14.58% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | ($0.11B) | $1.13B | $0.98B | $1.00B | $0.95B |
| Operating Income | $0.55B | $0.58B | $0.70B | $0.82B | $0.78B |
| Operating Margin %(computed) | 4.43% | 4.86% | 5.90% | 6.91% | 6.86% |
| Interest Income | $0.01B | $0.02B | $0.01B | $0.01B | $0.01B |
| Interest Expense | $0.14B | $0.13B | $0.10B | $0.07B | $0.08B |
| Income Before Tax | $0.51B | $0.47B | $0.61B | $0.76B | $0.71B |
| Income Tax Expense | $0.11B | $0.09B | $0.12B | $0.15B | $0.14B |
| Net Income | $0.40B | $0.38B | $0.50B | $0.61B | $0.57B |
| Net Margin %(computed) | 3.24% | 3.18% | 4.21% | 5.16% | 5.06% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.02 | $0.95 | $1.25 | $1.53 | $1.44 |
| Wtd Avg Shares | 0.40B | 0.40B | 0.40B | 0.40B | 0.40B |
| EBITDA | $1.25B | $1.22B | $1.25B | $1.32B | $1.28B |
| EBITDA Margin %(computed) | 10.00% | 10.26% | 10.60% | 11.22% | 11.29% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · EUR · B
深入了解Kesko Oyj
关于Kesko Oyj（KKOYF）损益表
Kesko Oyj（KKOYF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，KKOYF实现营收$12.47B，毛利润$0.30B（毛利率2.39%），净利润$0.40B（净利率3.24%）。
常见问题
KKOYF · 4 问Kesko Oyj（KKOYF）2025财年营收为$12.47B，同比up4.7%。
KKOYF revenueKKOYF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08